Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Björn Lemmer & Martin Middeke. (2020) Insufficient reply by Hermida et al. to the critical comments to the MAPEC and HYGIA studies. Chronobiology International 37:8, pages 1269-1269.
Read now
Read now
Ramón C. Hermida, Artemio Mojón & José R. Fernández. (2020) Ambulatory blood pressure-based inclusion criteria in the Hygia Chronotherapy Trial. Rebuttal to Lemmer and Middeke. Chronobiology International 37:8, pages 1270-1272.
Read now
Read now
Juan J. Crespo, Manuel Domínguez-Sardiña, Alfonso Otero, Ana Moyá, María T. Ríos, Elvira Sineiro, María C. Castiñeira, Pedro A. Callejas, Lorenzo Pousa, José L. Salgado, Carmen Durán & Juan J. Sánchez. (2020) The Hygia Project and Hygia Chronotherapy Trial: insights of we clinical investigators on the impact of the embedded continuing medical education on primary-care practice and improved patient cardiovascular health. Chronobiology International 37:5, pages 759-766.
Read now
Read now
Ramón C. Hermida, José R. Fernández & Artemio Mojón. (2020) Current evidence on the circadian-time-dependent effects of hypertension medications and their combinations in relation to findings of MAPEC and Hygia Chronotherapy Trial. Chronobiology International 37:5, pages 751-758.
Read now
Read now
José R. Fernández, Artemio Mojón & Ramón C. Hermida. (2020) Chronotherapy of hypertension: advantages of 48-h ambulatory blood pressure monitoring assessments in MAPEC and Hygia Chronotherapy Trial. Chronobiology International 37:5, pages 739-750.
Read now
Read now
Ramón C. Hermida, Artemio Mojón & José R. Fernández. (2020) Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as documented by MAPEC and Hygia Chronotherapy outcomes trials. Chronobiology International 37:5, pages 731-738.
Read now
Read now
Articles from other publishers (11)
Basel Abdelazeem, Othman Saleh, Abdelrahman Mahmoud & Mohamed Abuelazm. (2024) Authors’ response to “Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings”. Journal of Hypertension 42:1, pages 191-192.
Crossref
Crossref
Edward J. Filippone, Andrew J. Foy & Gerald V. Naccarelli. (2023) Controversies in Hypertension III: Dipping, Nocturnal Hypertension, and the Morning Surge. The American Journal of Medicine 136:7, pages 629-637.
Crossref
Crossref
Nadim El Jamal, Ronan Lordan, Sarah L. TeegardenTilo Grosser & Garret FitzGerald. (2023) The Circadian Biology of Heart Failure. Circulation Research 132:2, pages 223-237.
Crossref
Crossref
Chau Le Bao Ho & Christopher M. Reid. (2022) Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease. Exploration of Medicine 2:3, pages 461-467.
Crossref
Crossref
George Stergiou, Mattias Brunström, Thomas MacDonald, Konstantinos G. Kyriakoulis, Michael Bursztyn, Nadia Khan, George Bakris, Anastasios Kollias, Ariadni Menti, Paul Muntner, Marcelo Orias, Neil Poulter, Daichi Shimbo, Bryan Williams, Abiodun Moshood Adeoye, Albertino Damasceno, Lyudmila Korostovtseva, Yan Li, Elizabeth Muxfeldt, Yuqing Zhang, Giuseppe Mancia, Reinhold Kreutz & Maciej Tomaszewski. (2022) Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension. Journal of Hypertension 40:10, pages 1847-1858.
Crossref
Crossref
Husam M Salah & Jawahar L Mehta. (2022) Best time for administration of antihypertensive medications: morning or evening?. The Lancet 400:10361, pages 1383-1385.
Crossref
Crossref
Edward J. Filippone, Andrew J. Foy & Gerald V. Naccarelli. (2022) Controversies in Hypertension I: The Optimal Assessment of Blood Pressure Load and Implications for Treatment. The American Journal of Medicine 135:9, pages 1043-1050.
Crossref
Crossref
Iain J. McGurgan, Peter J. Kelly, Tanya N. Turan & Peter M. Rothwell. (2022) Long-Term Secondary Prevention: Management of Blood Pressure After a Transient Ischemic Attack or Stroke. Stroke 53:4, pages 1085-1103.
Crossref
Crossref
Nicole P. Bowles & Steven A. Shea. (2021) Is the bedtime ingestion of hypertensive medications effective and safe?. Sleep Medicine Reviews 59, pages 101511.
Crossref
Crossref
Chau L. B. Ho, Enayet K. Chowdhury, Jenny Doust, Mark R. Nelson & Christopher M. Reid. (2021) The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review. Journal of Human Hypertension 35:4, pages 308-314.
Crossref
Crossref
Christine B. Sethna, Lindsay G. Grossman, Preeta Dhanantwari, Shari Gurusinghe, Nina Laney, Rachel Frank & Kevin E. Meyers. (2020) Restoration of nocturnal blood pressure dip and reduction of nocturnal blood pressure with evening anti‐hypertensive medication administration in pediatric kidney transplant recipients: A pilot randomized clinical trial. Pediatric Transplantation 24:8.
Crossref
Crossref